Genital infections
Disease1 paper
Latest
2Clinical and Experimental HypertensionReview
Efficacy and mechanistic insights of dapagliflozin in hypertension management
Diabetes, Obesity & MetabolismHumans
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Adding a GLP-1 receptor agonist was linked to lower rates of major adverse kidney events (HR 0.70) compared with SGLT2 inhibitor monotherapy over 12…Adding a GLP-1 receptor agonist was linked to lower rates of major adverse kidney events (HR 0.70) compared with SGLT2 inhibitor monotherapy over 12 months.